flatexDEGIRO AG
OTC:FNNTF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
flatexDEGIRO AG
OTC:FNNTF
|
DE |
|
B
|
Biomarin Pharmaceutical Inc
XMUN:BM8
|
US |
|
A
|
Akamai Technologies Inc
XMUN:AK3
|
US |
Wall St Price Targets
FNNTF Price Targets Summary
flatexDEGIRO AG
According to Wall Street analysts, the average 1-year price target for FNNTF is 41.34 USD with a low forecast of 25.06 USD and a high forecast of 52.11 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FNNTF's stock price target?
Price Target
41.34
USD
According to Wall Street analysts, the average 1-year price target for FNNTF is 41.34 USD with a low forecast of 25.06 USD and a high forecast of 52.11 USD.
What is the Revenue forecast for flatexDEGIRO AG?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 12%.
What is the Gross Profit forecast for flatexDEGIRO AG?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 24%. The projected CAGR for the next 3 years is 10%.
What is the Operating Income forecast for flatexDEGIRO AG?
Projected CAGR
18%
Over the last 14 years, the compound annual growth rate for Operating Income has been 26%. The projected CAGR for the next 3 years is 18%.
What is the Pre-Tax Income forecast for flatexDEGIRO AG?
Projected CAGR
22%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 26%. The projected CAGR for the next 3 years is 22%.
What is the Net Income forecast for flatexDEGIRO AG?
Projected CAGR
22%
Over the last 14 years, the compound annual growth rate for Net Income has been 27%. The projected CAGR for the next 3 years is 22%.
